ENANTA PHARMACEUTICALS INC's ticker is ENTA and the CUSIP is 29251M106. A total of 156 filers reported holding ENANTA PHARMACEUTICALS INC in Q2 2022. The put-call ratio across all filers is 0.10 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $289,660 | +65.1% | 25,932 | +216.2% | 0.00% | 0.0% |
| Q2 2023 | $175,480 | -63.7% | 8,200 | -31.5% | 0.00% | 0.0% |
| Q1 2023 | $483,986 | -64.3% | 11,968 | -58.3% | 0.00% | -83.3% |
| Q2 2022 | $1,357,000 | +3891.2% | 28,700 | +7075.0% | 0.01% | – |
| Q2 2019 | $34,000 | -95.3% | 400 | -95.2% | 0.00% | -100.0% |
| Q3 2018 | $718,000 | -58.5% | 8,400 | -85.1% | 0.00% | -70.0% |
| Q1 2017 | $1,731,000 | – | 56,200 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Krensavage Asset Management, LLC | 511,186 | $43,686,000 | 11.23% |
| GREAT POINT PARTNERS LLC | 210,400 | $17,981,000 | 2.80% |
| ARMISTICE CAPITAL, LLC | 456,000 | $38,970,000 | 2.34% |
| Matarin Capital Management, LLC | 210,208 | $17,964,376,000 | 1.16% |
| Sapphire Star Partners LP | 8,168 | $698,000 | 0.70% |
| Granahan Investment Management | 103,320 | $8,830,000 | 0.48% |
| FARALLON CAPITAL MANAGEMENT LLC | 867,500 | $74,137,000 | 0.44% |
| 361 CAPITAL LLC | 19,040 | $1,627,000 | 0.35% |
| ALGERT GLOBAL LLC | 17,922 | $1,532,000 | 0.33% |
| AlphaMark Advisors, LLC | 9,310 | $796,000 | 0.32% |